0001048477-24-000073.txt : 20240506
0001048477-24-000073.hdr.sgml : 20240506
20240506164049
ACCESSION NUMBER: 0001048477-24-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240502
FILED AS OF DATE: 20240506
DATE AS OF CHANGE: 20240506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajer Jeffrey Robert
CENTRAL INDEX KEY: 0001557533
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 24918206
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
wk-form4_1715028037.xml
FORM 4
X0508
4
2024-05-02
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001557533
Ajer Jeffrey Robert
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO STREET
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Commercial Officer
1
Common Stock
2024-04-30
5
A
0
E
300
68.646
A
71767
D
Common Stock
2024-05-02
4
S
0
5000
82.91
D
66767
D
Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.
/s/ Tae Sang Yoo, Attorney-in-Fact
2024-05-06